Apnimed (APMD) overhauls charter and bylaws, adds 10M preferred share authorization
Rhea-AI Filing Summary
Apnimed, Inc. amended its corporate governance documents in connection with the consummation of its initial public offering. Immediately prior to the IPO, the company filed a Ninth Amended and Restated Certificate of Incorporation in Delaware, which authorizes 500,000,000 shares of common stock, eliminates all references to previously existing preferred stock series, and authorizes 10,000,000 shares of undesignated preferred stock that the board may issue in one or more series. At the same time, a Second Amended and Restated Bylaws became effective, establishing procedures for stockholder actions and director nominations, including advance notice requirements, and aligning the bylaws with the Restated Certificate.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Authorized common stock: 500,000,000 shares of common stock
Authorized preferred stock: 10,000,000 shares of undesignated preferred stock
Exchange listing: Nasdaq Global Select Market
3 metrics
Authorized common stock
500,000,000 shares of common stock
Authorized under the Ninth Amended and Restated Certificate of Incorporation
Authorized preferred stock
10,000,000 shares of undesignated preferred stock
Authorized under the Restated Certificate, issuable in one or more series
Exchange listing
Nasdaq Global Select Market
Listing venue for Apnimed’s common stock, trading under the symbol APMD
Key Terms
Ninth Amended and Restated Certificate of Incorporation, undesigned preferred stock, Second Amended and Restated Bylaws, advance notice procedure, +1 more
5 terms
Ninth Amended and Restated Certificate of Incorporation regulatory
"the Company filed its ninth amended and restated certificate of incorporation"
undesigned preferred stock financial
"authorize 10,000,000 shares of undesignated preferred stock that may be issued"
Second Amended and Restated Bylaws regulatory
"the second amended and restated bylaws of the Company became effective"
advance notice procedure regulatory
"establish an advance notice procedure for stockholder proposals to be brought"
emerging growth company regulatory
"Emerging growth company Item 5.03."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What corporate changes did Apnimed (APMD) make on August 3, 2026?
Apnimed implemented a Ninth Amended and Restated Certificate of Incorporation and Second Amended and Restated Bylaws. These documents update its capital structure and formalize stockholder and director nomination procedures in connection with the company’s initial public offering.
What preferred stock authorization did Apnimed (APMD) adopt?
Apnimed’s Restated Certificate authorizes 10,000,000 shares of undesignated preferred stock. The board of directors may issue these shares from time to time in one or more series, with rights and preferences set when each series is created.
Did Apnimed (APMD) change its existing preferred stock structure?
Yes. The Restated Certificate eliminates all references to previously existing series of preferred stock. This cleans up the prior capital structure while simultaneously authorizing a new pool of undesignated preferred shares under board control.
What do Apnimed’s new bylaws change about stockholder meetings and proposals?
The Second Amended and Restated Bylaws establish procedures for stockholder actions at meetings, including an advance notice procedure for proposals and director nominations, and set out rules governing how directors may be nominated for election to the board.
How do Apnimed’s new bylaws relate to its Restated Certificate?
The Second Amended and Restated Bylaws are designed to conform to the provisions of the Restated Certificate. They incorporate the updated capital structure and governance framework adopted in the new certificate of incorporation.